Developmental change in the glycosaminoglycan composition of the rat brain
- PMID: 3090203
- DOI: 10.1111/j.1471-4159.1986.tb04540.x
Developmental change in the glycosaminoglycan composition of the rat brain
Abstract
Glycosaminoglycans (GAGs) were isolated from the brains of pre-and postnatal rats. The GAG content of the brain, based on the amount of DNA, was constant during the period from day 13 to day 15 of gestation. After day 15, the GAG content began to increase and reached a plateau by 10 days after birth. Hyaluronate (HA) was the main GAG (greater than 60% of the total) in the fetal rat brain, and the relative amount of HA decreased after birth. Conversely, the relative amount of chondroitin sulfate increased with development and reached the adult level by 20 days after birth. Heparan sulfate (HS) was the major sulfated GAG in the fetal rat brain at early developmental stages, but HS accounted for approximately 10% of the total GAG in the postnatal brains. In addition to these GAGs, a polysialosyl glycoconjugate was isolated from rapidly growing brains of the rat. These three GAGs could be isolated either from the cerebellum, cerebrum, or brainstem of the newborn rat. A closely similar age-related change in the GAG composition was observed in each of these different regions of the brain. The developmental change could be implicated in morphogenesis or maturation of the brain.
Similar articles
-
Sulfated glycosaminoglycans (GAG) in the developing mouse brain. Quantitative aspects on the metabolism of total and individual sulfated GAG in vivo.Dev Biol. 1987 Apr;120(2):447-56. doi: 10.1016/0012-1606(87)90248-x. Dev Biol. 1987. PMID: 3104114
-
Developmental and age-related changes in rat brain glycosaminoglycans.J Neurochem. 1988 Nov;51(5):1634-40. doi: 10.1111/j.1471-4159.1988.tb01134.x. J Neurochem. 1988. PMID: 3139839
-
Developmental change in the glycosaminoglycan composition of the chick embryo brain.Boll Soc Ital Biol Sper. 1990 Jul;66(7):655-61. Boll Soc Ital Biol Sper. 1990. PMID: 2128022
-
Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders.Annu Rev Biomed Eng. 2017 Jun 21;19:1-26. doi: 10.1146/annurev-bioeng-071516-044610. Epub 2017 Feb 2. Annu Rev Biomed Eng. 2017. PMID: 28226217 Review.
-
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.Biomolecules. 2021 Mar 8;11(3):395. doi: 10.3390/biom11030395. Biomolecules. 2021. PMID: 33800172 Free PMC article. Review.
Cited by
-
Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):245-51. Biochem J. 2000. PMID: 10926850 Free PMC article.
-
Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease.Biochem J. 1995 Feb 15;306 ( Pt 1)(Pt 1):177-84. doi: 10.1042/bj3060177. Biochem J. 1995. PMID: 7864807 Free PMC article.
-
Chondroitin sulfate "wobble motifs" modulate maintenance and differentiation of neural stem cells and their progeny.J Biol Chem. 2012 Jan 27;287(5):2935-42. doi: 10.1074/jbc.R111.298430. Epub 2011 Nov 17. J Biol Chem. 2012. PMID: 22094467 Free PMC article. Review.
-
Structural analysis of glycosaminoglycans derived from axonally transported proteoglycans in regenerating goldfish optic nerve.Neurochem Res. 1995 Mar;20(3):253-9. doi: 10.1007/BF00969540. Neurochem Res. 1995. PMID: 7609824
-
Functions of chondroitin sulfate and heparan sulfate in the developing brain.Neurochem Res. 2011 Jul;36(7):1228-40. doi: 10.1007/s11064-010-0324-y. Epub 2010 Nov 26. Neurochem Res. 2011. PMID: 21110089 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources